Raymond James & Associates Organon & Co. Call Options Transaction History

Raymond James & Associates

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 08, 2023	BUY	$23.31 - $28.61 $279,720 - $343,320	12,000 New	12,000 $335,000
Q2 2022 Aug 12, 2022	SELL	$31.66 - $38.9 $687,022 - $844,130	-21,700 Reduced 58.49%	15,400 $75,000
Q1 2022 May 11, 2022	SELL	$30.45 - $39.36 $697,305 - $901,344	-22,900 Reduced 38.17%	37,100 $69,000
Q4 2021 Feb 08, 2022	BUY	$28.67 - $37.13 $825,696 - $1.07 Million	28,800 Added 92.31%	60,000 $50,000
Q3 2021 Nov 02, 2021	BUY	$28.63 - $35.64 $893,256 - $1.11 Million	31,200 New	31,200 $36,000

793

192M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.93B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.